Hyponatremia – carbamazepine medication complications

Česká verzia

Authors: I. Dedinská; V. Maňka; I. Ságová; A. Klimentová; P. Makovický; J. Polko; J. Sadloňová; M. Mokáň
Authors place of work: I. interná klinika Lekárskej Fakulty UK a UN Martin, Slovenská republika, prednosta prof. MUDr. Marián Mokáň, DrSc., FRCP Edin
Published in the journal: Vnitř Lék 2012; 58(1): 72-75
Category: Case Reports

Summary

Hyponatremia can be defined like the low sodium concentration, lower that 135 mmol/l. It becomes really serious when the concentration is lower than 120 mmol/l. The most frequent causes of hyponatremia are: the extrarenal loss (GIT, skin, bleeding, sequestration), the renal loss (diuretics, nephritis with the salt loss, osmotical diuresis, the Addison disease), hypothyroidism, the lack of glucocorticoids, emotional stress, pain, pseudohyponatremia (incorrect taking, dyslipoproteinemia). There is fatigue, exhaustion, headache and vertigoes dominating in the clinical record file. By the deficit increasing a patient becomes delirious, comatose even with the shock development. It is necessary to separate sufficient supply of sodium from much more often reason, which is loss of sodium which can be caused by: excessive sweating, vomitting with the metabolical alkalosis development, diarrhoea with the metabolical acidosis development, renal losses (a phase of renal failure). Treatment of hyponatremia: intensive treatment starts at the level of plasmatic concentration of sodium under 120 mmol/l or when neurological symptoms of brain oedema are present. In the therapy it is necessary to avoid fast infusions of hypertonic saline solutions (3–5% NaCl solutions) because of the danger of the development of serious CNS complications (intracranial bleeding, etc.). It is recommended to adjust the plasmatic concentration of sodium up to 120 mmol/l during the first four hours and a subsequent correction shoud not be higher than 2 mmol per an hour. Treatment of the basic illness is very important. We present 2 case histories: a 74-year old female patient and a 69-year old female patient both with the hyponatremia caused by taking of carbamazepine. We want to inform and warn about not only a well known side effect duringlong-term treatment but about hyponatremia that arose within 48 hours after the start of taking medicine as well.

Key words:
hyponatermia – carbamazepine – epilepsy – side effect

Zdroje

1. Dzúrik R, Trnovec T (eds). Štandardné terapeutické postupy. Martin: Osveta 2001; 390–392.

2. Ďuriš I, Hulín I, Bernadič M (eds). Princípy internej medicíny. Bratislava: SAP 2001: 619.

3. Peters JP, Welt LG, Sims EA et al. A salt-wasting syndrome associated with cerebral disease. Trans Assoc Am Physicians 1950; 63: 57–64.

4. Betjes MG. Hyponatremia in acute brain disease: the cerebral salt wasting syndrome. Eur J Intern Med 2002; 13: 9–14.

5. Harrigan MR. Cerebral salt wasting syndrome: a review. Neurosurgery 1996; 38: 152–160.

6. Ranta A, Wooten GF. Hyponatremia due to an additive effect of carbamazepin and thiazide diuretics. Epilesia 2004; 45: 879.

7. Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med 2000; 342: 1581–1589.

8. Osorio I, Reed RC, Peltzer JN. Refractory idiopathic absence status epilepticus: a probable paradoxial effect of phenytoin and carbamazepine. Epilepsia 2000; 41: 887–894.

9. Alegre Herrera S, Araujo Sanbria J, Rubio JM. Clarithromycin-carbamazepine interaction: neurological symptoms and hyponatremia. Ann Med Interna 1998; 15: 48–49.

10. Palmer BF, Gates JR, Lader M. Causes and management of hyponatrimia. Ann Pharmacother 2003; 37: 1694–1702.

11. Dong X, Leppik IE, White J et al. Hyponatremia from oxcarbazepine and carbamazepine. Neurology 2005; 65: 1967–1978.